Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Ory

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Oncotarget|August 21, 2014
Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcomaFrancois Lamoureux, Marc Baud'huin, Benjamin Ory, et al.
Cancer Letters|December 17, 2013
NVP-BEZ235, a dual PI3K/mTOR inhibitor, inhibits osteosarcoma cell proliferation and tumor development in vivo with an improved survival rateBérengère Gobin, Séverine Battaglia, Rachel Lanel, et al.
Plos One|March 7, 2014
Imatinib mesylate exerts anti-proliferative effects on osteosarcoma cells and inhibits the tumour growth in immunocompetent murine modelsBérengère Gobin, Gatien Moriceau, Benjamin Ory, et al.
Journal of Bone Oncology|June 1, 2018
Small animal models for the study of bone sarcoma pathogenesis:characteristics, therapeutic interests and limitationsCamille Jacques, Nathalie Renema, Frederic Lezot, et al.
The Journal of Clinical Investigation|July 23, 2013
FGFR2 signaling underlies p63 oncogenic function in squamous cell carcinomaMatthew R Ramsey, Catherine Wilson, Benjamin Ory, et al.
Epigenomics|April 8, 2024
Super-enhancers: drivers of cells' identities and cells' debaclesMélanie Lavaud, Robel Tesfaye, Léa Lassous, et al.
International Journal of Cancer|October 26, 2007
Relevance of a new rat model of osteoblastic metastases from prostate carcinoma for preclinical studies using zoledronic acidFrançois Lamoureux, Benjamin Ory, Séverine Battaglia, et al.
Molecular Therapy. Nucleic Acids|September 11, 2020
N6-Adenosine Methylation of miRNA-200b-3p Influences Its Functionality and Is a Theranostic ToolJoséphine Briand, Aurélien A Sérandour, Arulraj Nadaradjane, et al.
Cancers|December 11, 2022
The p53 Family Members p63 and p73 Roles in the Metastatic Dissemination: Interactions with microRNAs and TGFβ PathwayLidia Rodriguez Calleja, Melanie Lavaud, Robel Tesfaye, et al.
The Journal of Clinical Investigation|February 5, 2011
A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinomaBenjamin Ory, Matthew R Ramsey, Catherine Wilson, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Oncotarget|August 21, 2014
Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcomaFrancois Lamoureux, Marc Baud'huin, Benjamin Ory, et al.
Cancer Letters|December 17, 2013
NVP-BEZ235, a dual PI3K/mTOR inhibitor, inhibits osteosarcoma cell proliferation and tumor development in vivo with an improved survival rateBérengère Gobin, Séverine Battaglia, Rachel Lanel, et al.
Plos One|March 7, 2014
Imatinib mesylate exerts anti-proliferative effects on osteosarcoma cells and inhibits the tumour growth in immunocompetent murine modelsBérengère Gobin, Gatien Moriceau, Benjamin Ory, et al.
Journal of Bone Oncology|June 1, 2018
Small animal models for the study of bone sarcoma pathogenesis:characteristics, therapeutic interests and limitationsCamille Jacques, Nathalie Renema, Frederic Lezot, et al.
The Journal of Clinical Investigation|July 23, 2013
FGFR2 signaling underlies p63 oncogenic function in squamous cell carcinomaMatthew R Ramsey, Catherine Wilson, Benjamin Ory, et al.
Epigenomics|April 8, 2024
Super-enhancers: drivers of cells' identities and cells' debaclesMélanie Lavaud, Robel Tesfaye, Léa Lassous, et al.
International Journal of Cancer|October 26, 2007
Relevance of a new rat model of osteoblastic metastases from prostate carcinoma for preclinical studies using zoledronic acidFrançois Lamoureux, Benjamin Ory, Séverine Battaglia, et al.
Molecular Therapy. Nucleic Acids|September 11, 2020
N6-Adenosine Methylation of miRNA-200b-3p Influences Its Functionality and Is a Theranostic ToolJoséphine Briand, Aurélien A Sérandour, Arulraj Nadaradjane, et al.
Cancers|December 11, 2022
The p53 Family Members p63 and p73 Roles in the Metastatic Dissemination: Interactions with microRNAs and TGFβ PathwayLidia Rodriguez Calleja, Melanie Lavaud, Robel Tesfaye, et al.
The Journal of Clinical Investigation|February 5, 2011
A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinomaBenjamin Ory, Matthew R Ramsey, Catherine Wilson, et al.
Pageof 6